qaybta jilicsan ee alveolar sarcoma, Atezolizumab, Nidaamka dhexe ee dareenka, Genentech, Tecentriq
Atezolizumab waxa u ansixisay FDA ee sarcoma unugyada jilicsan ee alveolar
Dec 2022: Atezolizumab (Tecentriq, Genentech, Inc.) waxaa ansixisay Maamulka Cuntada iyo Dawooyinka (FDA) ee loogu talagalay bukaanada qaangaarka ah iyo carruurta ee leh qaybta jilicsan ee alveolar ee aan la soo saari karin ama metastatic sarcoma kuwaas oo ah 2 sano